中华交易服务香港生物科技指数下跌1.85%，前十大权重包含金斯瑞生物科技等

Core Viewpoint - The CESHKB index has shown significant growth, with a year-to-date increase of 123.13%, indicating a strong performance in the biotechnology sector listed in Hong Kong [1][2]. Group 1: Index Performance - The CESHKB index opened high but experienced a decline of 1.85%, closing at 9813.36 points with a trading volume of 19.304 billion [1]. - Over the past month, the CESHKB index has risen by 12.30%, and over the last three months, it has increased by 73.10% [1]. Group 2: Index Composition - The CESHKB index is compiled by China Securities Index Co., Ltd. under the commission of China Securities Trading Service Co., Ltd., reflecting the overall performance of biotechnology companies listed in Hong Kong [1]. - The top ten holdings in the CESHKB index include: - CanSino Biologics (14.32%) - Innovent Biologics (9.54%) - BeiGene (8.5%) - 3SBio (8.48%) - WuXi Biologics (8.32%) - WuXi AppTec (6.53%) - Kintor Pharmaceutical (5.21%) - Zai Lab (4.35%) - Ascletis Pharma (4.17%) - Kingstar Biotech (3.84%) [1]. Group 3: Market and Industry Overview - The CESHKB index is entirely composed of companies listed on the Hong Kong Stock Exchange, with a 100% representation from the healthcare sector [2].